Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Mirtazapine

Mirtazapine
In stock
7.5mg · 15mg · 30mg
from A$60.85
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$73.02A$60.85
A$2.03 per tablet

In brief

  • Mirtazapine is supplied in pharmacies and via prescribers (GPs, psychiatrists); it is classified as prescription-only (Rx) in Australia and most countries — buying from unregulated sources without a prescription is not recommended and may be illegal or unsafe.
  • Mirtazapine is used primarily for major depressive disorder and off-label for insomnia, anxiety, appetite stimulation and nausea; it is a noradrenergic and specific serotonergic antidepressant (NaSSA) that antagonises central α2‑adrenergic receptors and certain 5‑HT receptors, increasing noradrenaline and serotonin neurotransmission while blocking 5‑HT2/5‑HT3 receptors.
  • Usual adult dose is 15–45 mg once daily at bedtime (commonly start 15 mg); lower starting doses (7.5–15 mg) are used for elderly or those sensitive to sedation, with cautious upward titration as needed.
  • Oral administration: tablets (7.5, 15, 30, 45 mg), orodispersible tablets (15, 30, 45 mg) and occasional oral solution formulations; no routine injectable or topical forms.
  • Some clinical improvement may be noticed within 1–2 weeks, sedative effects can occur within hours of the first dose; full antidepressant response often requires 4–6 weeks.
  • Effects are sustained with once‑daily dosing (typically cover ~24 hours); elimination half-life is roughly 20–40 hours so steady state and washout are relatively slow.
  • Do not drink alcohol with mirtazapine — alcohol increases sedation, cognitive impairment and the risk of respiratory depression and falls.
  • The most common side effect is somnolence/sedation (other frequent effects include increased appetite and weight gain, dry mouth, dizziness, constipation and fatigue).
  • Would you like to try mirtazapine without a prescription?

Basic Mirtazapine Information

  • INN (International Nonproprietary Name): Mirtazapine
  • Brand Names Available In Australia: Avanza
  • ATC Code: N06AX11
  • Forms & Dosages: Tablets 7.5 mg (rare), 15 mg, 30 mg, 45 mg; Orodispersible tablets 15 mg, 30 mg, 45 mg; oral solution not universally available; no injectable or topical formulations for routine use.
  • Manufacturers In Australia: Supplied globally by Organon, Teva, Sandoz, HEXAL, ratiopharm, Sun Pharma, Mylan and regional generic producers (local repackagers vary).
  • Registration Status In Australia: TGA approved; prescription only (Rx).
  • OTC / Rx Classification: Prescription only (Rx).

Critical Warnings & Restrictions

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

  • Safety First: Mirtazapine causes marked sedation and can increase fall risk in older Australians.
  • Start Low: Begin at 7.5–15 mg in frail or elderly patients and monitor for postural hypotension and sedation.
  • Severe Hepatic/Renal Impairment: Use caution and monitor; start at lowest dose and titrate slowly.
  • Seizure Or Bipolar History: Exercise caution; consult psychiatry before starting.
  • Pregnancy & Breastfeeding: Require specialist review; discuss risks and benefits with an obstetrician and psychiatrist.
  • Absolute Contraindication Checklist:
    • Concurrent Or Recent MAOI Use: Do not use if a monoamine oxidase inhibitor has been taken within the past 14 days.
    • Known Hypersensitivity: Avoid if allergic to mirtazapine or excipients.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

  • Sedation, slowed reaction time and dizziness are common early effects and can impair driving and operation of heavy machinery.
  • Employers and clinicians must consider duty‑of‑care and occupational safety requirements when a staff member starts mirtazapine.
  • Advise patients not to drive or operate dangerous equipment until they know how the medicine affects them.
  • Document counselling on driving and workplace safety in the patient record or pharmacy notes.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: No until you know how it affects you.

If you feel sedated or dizzy do not drive or operate machinery.

Follow your GP or pharmacist’s advice and local road rules.

Note that mirtazapine is TGA approved and prescription‑only when giving safety counselling.

Usage Basics

INN, Brand Names Available In Australia

  • International Nonproprietary Name: mirtazapine.
  • Common Australian brand: Avanza; international brands include Remeron, Zispin and Mirtazapine Sandoz.
Brand / Market Common Dosages
Avanza (Australia, NZ) 15 mg, 30 mg, 45 mg tablets
Remeron / Remeron RD (US, Canada) 7.5 mg, 15 mg, 30 mg, 45 mg tablets
Zispin / Mirtazapine Sandoz (Europe, UK) Orodispersible 15 mg, 30 mg, 45 mg; film tabs 15–45 mg

Legal Classification (TGA‑Approved, PBS‑Listed)

  • Mirtazapine is TGA approved and prescription‑only (Rx) in Australia.
  • PBS subsidy status can vary by formulation and indication; confirm current PBS schedule or authority requirements before advising on cost.
  • Pharmacists routinely dispense under standard and authority prescriptions and accept telehealth e‑prescriptions.
  • Definitions:
  • INN: International Nonproprietary Name — Mirtazapine.
  • ATC Code: N06AX11.
  • Rx Status: Prescription only per TGA.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Situation Typical Starting/Titration Regimen
Adult MDD 15 mg once daily at bedtime, titrate to 15–45 mg qhs as needed
Severe Insomnia / Frail Start 7.5–15 mg at bedtime, increase cautiously
  • Therapeutic effect often begins after 1–2 weeks; full response may take 4–6 weeks.
  • Treatment usually continued 6–12 months after remission; gradual tapering reduces withdrawal risk.

Adjustments For Comorbidities

  • Elderly: Start low (7.5–15 mg) and titrate slowly to reduce sedation and orthostatic hypotension.
  • Liver impairment: Start at lowest dose and monitor for increased drug levels.
  • Renal impairment: Monitor and use caution in severe renal disease.
  • Bipolar disorder or seizure history: Consult psychiatry before prescribing.
Condition Dosing Adjustment
Elderly / Frail Start 7.5–15 mg; slow titration and fall‑risk monitoring
Hepatic Impairment Start lowest dose; monitor for sedation and toxicity
Severe Renal Disease Use with caution; close monitoring advised

Q&A — “What If I Miss A Dose?”

Take the missed dose when you remember unless it is close to the time for your next dose.

Do not double up doses to make up for a missed tablet.

Contact your prescriber if several doses have been missed or for tailored advice.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

  • Alcohol markedly increases sedation and risk of respiratory/CNS depression; avoid or minimise alcohol while taking mirtazapine.
  • Caffeine may counter sedation but can worsen anxiety or insomnia in some people.
  • Consider typical Australian evening drinking patterns and energy‑drink use when counselling about safety at night or before driving.
  • Patient Checklist:
  • Avoid alcohol while starting the medicine.
  • Limit energy drinks and late‑day coffee if sleep is a concern.
  • Report any increased drowsiness or unusual effects to your pharmacist or GP.

Common Drug Conflicts

Drug / Class Interaction Level Monitoring Points
MAOIs Absolute contraindication Stop MAOI ≥14 days before starting mirtazapine
Other Serotonergic Agents Caution — serotonin syndrome risk Watch for agitation, fever, tremor; consult prescriber
CNS Depressants (Benzodiazepines, Opioids, Antihistamines) Moderate to high Increased sedation; consider dose adjustments and monitoring
QT‑Prolonging Drugs / Cardiac Conduction Agents Caution Review ECG and cardiac history if clinically indicated
Drugs Metabolised By Hepatic CYP Enzymes Variable Monitor for altered effects or toxicity

Advise patients to provide a full medication list to their pharmacist or GP including OTC, herbal and recreational substances.

User Reports & Trends

  • Common themes from Australian patient feedback include a rapid improvement in sleep and significant daytime sedation early in treatment.
  • Many patients notice increased appetite and subsequent weight gain while on mirtazapine.
  • Other commonly reported effects are vivid dreams and dry mouth.
  • Rural patients report longer waits for GP appointments but good support from community pharmacists and increased access via telehealth.

Short Quote Exemplar: “My sleep improved within days but I felt groggy for the first two weeks and put on a few kilos.”

  • Safety Trends: Reports to regulators emphasise falls and sedation in older patients and rare blood dyscrasias.
  • Escalation Checklist: Arrange urgent review for unexplained bruising, sore throat, fever or symptoms suggesting blood dyscrasia; consider CBC.
Adverse Effect Frequency (Product Data)
Somnolence / Sedation Common (≥1%)
Increased Appetite / Weight Gain Common (≥1%)
Dry Mouth, Dizziness, Constipation Common (≥1%)
Blood Dyscrasias Rare (monitor CBC if indicated)

Counsel patients about weight and metabolic monitoring, especially if appetite increases.

Access & Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Chain Stock Counselling & Delivery
Chemist Warehouse Avanza and generic mirtazapine tablets commonly stocked; ODT availability varies In‑store counselling, repeats processing, click & collect, delivery options
Priceline Common generics and brands; ODT availability varies Pharmacist counselling, loyalty pricing, delivery
TerryWhite Chemmart Stock varies by store; can order specific brands Clinical counselling, home delivery and rural outreach services

Online Pharmacies And Telehealth E‑Prescriptions

  • Telehealth e‑prescriptions are accepted by Australian pharmacies and increase access for rural patients.
  • Use accredited online pharmacies and request pharmacist counselling by phone or video before dispatch.
  • Check pharmacy registration (AHPRA/TGA/other accreditation), prescription verification and secure delivery options.
  • Safe Online Purchase Checklist:
  • Confirm pharmacy accreditation and active registration.
  • Ensure prescription verification and clear pharmacist contact details.
  • Use secure payment and track deliveries.

In our online pharmacy, mirtazapine is available without a prescription, with discreet delivery to Australia in 9-21 days.

  • Practical Tip: Compare PBS subsidy status and shop around for price variations at major chains before paying out of pocket.

Mechanism & Pharmacology

Simplified Explanation

  • Mirtazapine is a tetracyclic or “other” antidepressant with ATC code N06AX11.
  • It antagonises central presynaptic alpha‑2 receptors, increasing noradrenaline and serotonin release.
  • It blocks specific 5‑HT receptors and strongly antagonises H1 histamine receptors, which explains prominent sedation.
  • These combined actions underlie antidepressant, anxiolytic and sleep‑promoting effects.

Clinical Terms

  • H1 Antagonism: Causes sedation and increased appetite.
  • Alpha‑2 Antagonism: Enhances monoamine release and supports antidepressant effect.
  • 5‑HT2/3 Antagonism: May reduce sexual dysfunction relative to some SSRIs and can have antiemetic effects.
  • Metabolism occurs predominantly via hepatic enzymes so dose adjustments are advised in hepatic impairment.

Suggestion For Patient Materials: A simple labelled diagram showing “H1 → sleep/appetite” and “Alpha‑2 → mood” helps patients understand why the medicine is taken at night and why weight and sedation are monitored.

Indications & Off‑Label Uses

Approved Indications By TGA

Indication Population Formulations
Major Depressive Disorder Adults Tablets 15–45 mg; ODTs commonly 15–45 mg

Off‑Label Uses In Australian Clinical Practice

  • Short‑term insomnia secondary to depression.
  • Appetite stimulation in oncology and palliative care.
  • Depression with prominent insomnia or poor appetite.
  • Occasional use for nausea in selected patients.
  • Paediatric use is not routine and requires specialist oversight.
Off‑Label Use Evidence Strength (Practical)
Insomnia Secondary To Depression Moderate (clinical experience supports short‑term benefit)
Appetite Stimulation Moderate (used in palliative settings)
Nausea Limited (occasional use)

Clinicians should document rationale for off‑label prescribing and counsel patients on evidence, alternatives and monitoring.

Key Clinical Findings

  • Randomised trials and meta‑analyses show mirtazapine’s efficacy in major depressive disorder comparable to SSRIs and SNRIs.
  • Mirtazapine often provides earlier improvements in sleep and appetite than some other antidepressants.
  • Adverse effect profile differs: more sedation and weight gain, less sexual dysfunction than many SSRIs.
  • Australian clinic data and safety reports highlight fall risk in the elderly and recommend metabolic monitoring.
Outcome Typical Onset Monitoring Parameter
Mood Improvement 2–6 weeks Depression rating, GP/psychiatry follow‑up
Sleep Benefit Days to 2 weeks Sleep diary, sedation assessment
Weight Gain Weeks to months Baseline weight and periodic checks
Blood Dyscrasia Variable CBC if clinically indicated
  • Monitoring Schedule Checklist: baseline assessment, review at 2–4 weeks, 6–12 weeks, then ongoing as clinically required.
  • Always consult the latest RANZCP guidelines and local hospital policies for up‑to‑date recommendations.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Class / Example Typical Dose Range Pros Cons PBS Status
SSRI — Sertraline 50–200 mg daily Well tolerated; anxiolytic effects Sexual side effects common PBS listed
SNRIs — Venlafaxine 75–225 mg daily Helps neuropathic pain and anxiety Withdrawal symptoms possible; BP effects PBS listed
Trazodone 50–150 mg nightly (sedating) Good for insomnia Daytime sedation, orthostatic effects Available; PBS varies
Bupropion 150–300 mg daily Lower sexual side effects Not TGA‑approved for anxiety; seizure risk PBS status varies
Agomelatine 25–50 mg nightly Helps circadian rhythm and sleep Liver monitoring required PBS status varies

Pros And Cons Checklist

  • Match drug to symptom profile: insomnia/appetite vs daytime activation.
  • Consider side‑effect priorities: sexual function versus sedation.
  • Review comorbidities such as cardiac disease or seizure disorder before selection.
  • Discuss drug interactions and PBS cost or authority requirements with the patient.
  • Plan switching strategies and cross‑taper with specialist input where needed.

Common Questions

  • Will I Gain Weight? Increased appetite and weight gain are common; monitor weight and advise on diet and exercise.
  • Does It Cause Sexual Dysfunction? Incidence is lower than many SSRIs but sexual side effects can still occur.
  • How Long To Work? Sleep benefit may start within days; mood improvement commonly 2–6 weeks.
  • Can I Drink Alcohol? Avoid alcohol while taking mirtazapine because of increased sedation risk.
  • What Are Withdrawal Symptoms? Dizziness, agitation and insomnia can occur; taper slowly rather than stopping abruptly.

Escalation Checklist For Pharmacists

  • Immediate referral for severe sedation, loss of consciousness or overdose symptoms.
  • Urgent medical review for suicidal ideation or worsening mood.
  • Assess and refer for symptoms suggesting serotonin syndrome: agitation, fever, tremor, hyperreflexia.
  • Advise ED or GP for hypersensitivity reactions or signs of blood dyscrasia.

Suggestion: Use a simple decision flowchart in the dispensary to triage severe side effects and referral pathways.

Price & Access Comparison Table

Comparison Table — Pharmacy / Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Pharmacy / Source Formulation Typical Price Range PBS Subsidy Prescription Required
Chemist Warehouse Avanza / Generic tablets Varies — check live listings May be PBS subsidised depending on authority Yes
Priceline Brand / Generic tablets, ODT varies Varies — check live listings Check PBS schedule Yes
TerryWhite Chemmart Brand / Generic Varies May require authority prescription Yes
Accredited Online Pharmacies Generic tablets, ODT availability varies Varies Check PBS Yes

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Verify PBS eligibility and whether an authority prescription is required.
  • Request repeats where appropriate to avoid treatment interruptions.
  • Use telehealth scripts and e‑prescriptions for rural patients.
  • Confirm availability of orodispersible tablets if needed for swallowing issues.
  • Ask your pharmacist about generics such as Mirtazapine Sandoz or APX‑Mirtazapine variants to reduce cost.

Registration & Regulation

TGA Approval

  • Mirtazapine is TGA approved as a prescription antidepressant in Australia.
  • Local product labels follow TGA‑registered product information for contraindications, interactions and adverse events.
  • Clinicians should consult the TGA product information or sponsor data for up‑to‑date safety information.

PBS Subsidy Details

  • PBS listing and subsidy criteria may depend on formulation and indication; some uses require authority prescriptions.
  • Steps To Verify PBS Status:
  • Check the current PBS Schedule online or via hospital/local HealthPathways.
  • Confirm whether the prescribed formulation and indication qualify for subsidy or require an authority code.
  • Report adverse events via the TGA or local hospital pharmacovigilance systems; pharmacists can lodge reports for patients.

Storage & Handling

Household Storage In Australian Climate (Heat / Humidity)

  • Store at 15–30°C and avoid moisture and direct sunlight.
  • Do not keep tablets in the bathroom; choose a cool, dry place during hot and humid summers.
  • Keep in original packaging until use and out of reach of children and pets.
  • Emergency Disposal Steps: return unwanted medicines to a community pharmacy or follow local council disposal guidelines; do not flush.

Cold‑Chain Handling For Pharmacies

  • No cold‑chain required for finished tablet or ODT products.
  • Standard pharmacy storage conditions are acceptable; monitor expiry dates and maintain secure dispensing records.
  • Follow community return‑of‑medicines schemes where available for disposals.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

  • Key Points To Tell Patients: take mirtazapine at bedtime, do not drive until you know how it affects you, avoid alcohol, expect sedation and appetite changes.
  • Advise monitoring of weight and mood and schedule follow‑up at 2–4 weeks and again at 6–12 weeks.
  • Document all counselling in the patient record and provide written information where possible.

Patient Advice From PBS And National Health Authorities

  • Encourage adherence to prescribed dosing and the recommended length of therapy, typically 6–12 months after remission.
  • Report suicidal thoughts or severe side effects immediately and use local support services such as Lifeline or GP mental health crisis teams.
  • Pharmacists should advise on repeat prescriptions, PBS authority processes and when to refer to psychiatry.
  • Provide a printed “What To Expect” card covering onset timeline, common side effects, emergency signs and contact numbers.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 14-21 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Cairns Queensland 14-21 days
Townsville Queensland 14-21 days
Bendigo Victoria 14-21 days

Related products